A year in review: Mangoceuticals Inc (MGRX)’s performance in the last year

While Mangoceuticals Inc has overperformed by 1.55%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, MGRX fell by -58.95%, with highs and lows ranging from $7.66 to $1.32, whereas the simple moving average fell by -30.55% in the last 200 days.

Analysis of Mangoceuticals Inc (MGRX)

Further, the quarter-over-quarter decrease in sales is -48.95%, showing a negative trend in the upcoming months.

There are several well-rounded types of analysis and research techniques that can be used to gain a clear view of Mangoceuticals Inc’s future performance, with equity being one of the most critical indicators. The goal here is to ensure that your current return on equity of -115.87% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 0.12, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.

As an indicator of volatility for any stock, average volume can also be very valuable, and MGRX is recording an average volume of 304.60K. On a monthly basis, the volatility of the stock is set at 6.65%, whereas on a weekly basis, it is put at 3.39%, with a loss of -1.75% over the past seven days.

How Do You Analyze Mangoceuticals Inc Shares?

Apart from looking at the fundamentals, you should also pay attention to the number of company employees who own shares. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 51.44%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 0.76% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.

MGRX shares are owned by institutional investors to the tune of 0.76% at present.

Hot this week

Do investors need to be concerned about Green Plains Inc (GPRE)?

While Green Plains Inc has underperformed by -4.57%, investors...

Investing in Vital Energy Inc (VTLE) might be an excellent idea, but the stock is currently overvalued/undervalued

While Vital Energy Inc has underperformed by -5.69%, investors...

Can you now get a good deal on Lineage Cell Therapeutics Inc’s shares?

While Lineage Cell Therapeutics Inc has overperformed by 1.67%,...

AST SpaceMobile Inc (ASTS) deserves closer scrutiny

While AST SpaceMobile Inc has overperformed by 1.31%, investors...

Novavax, Inc (NVAX) produces promising results

While Novavax, Inc has overperformed by 1.41%, investors are...

Topics

Do investors need to be concerned about Green Plains Inc (GPRE)?

While Green Plains Inc has underperformed by -4.57%, investors...

Can you now get a good deal on Lineage Cell Therapeutics Inc’s shares?

While Lineage Cell Therapeutics Inc has overperformed by 1.67%,...

AST SpaceMobile Inc (ASTS) deserves closer scrutiny

While AST SpaceMobile Inc has overperformed by 1.31%, investors...

Novavax, Inc (NVAX) produces promising results

While Novavax, Inc has overperformed by 1.41%, investors are...

How did Ranpak Holdings Corp (PACK) fare last session?

While Ranpak Holdings Corp has overperformed by 4.24%, investors...

Is Sarepta Therapeutics Inc (SRPT) a opportunity to investors?

While Sarepta Therapeutics Inc has overperformed by 1.35%, investors...

A stock that deserves closer examination: Castellum Inc (CTM)

Within its last year performance, CTM fell by -46.00%,...
spot_img

Related Articles

Popular Categories

spot_imgspot_img
US Post News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.